A Biomedical DARPA? Yes, But Not at NIH

Creating a health-research counterpart to DARPA, the Pentagon's legendary Defense Advanced Research Project Agency, makes tremendous sense. DARPA, the freewheeling, cash-laden nest of sci-tech wizards, sired the Internet, stealth technology, the global positioning system, the Predator unmanned aircraft, and many more innovations throughout the Cold War and beyond. Call the biomedical version BARPA, and let it roll. Great. But if it's going to happen--and there's currently an influential prop

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Creating a health-research counterpart to DARPA, the Pentagon's legendary Defense Advanced Research Project Agency, makes tremendous sense. DARPA, the freewheeling, cash-laden nest of sci-tech wizards, sired the Internet, stealth technology, the global positioning system, the Predator unmanned aircraft, and many more innovations throughout the Cold War and beyond.

Call the biomedical version BARPA, and let it roll. Great. But if it's going to happen--and there's currently an influential proposal to do just that--do it right. Simply producing another stillborn bureaucracy (read: National Institutes of Health) that is obsessed with fulfilling every nit-picking piece of federal paperwork represents waste at its worst.

Antibureaucratic and nimble, DARPA has long attracted envious glances from scientists and research managers, frustrated by the elephantine workings of the NIH, that colossus of biomedical research. NIH is renowned, rich, and politically coddled as the headquarters of America's war on diseases. With its bountiful billions, it has underwritten ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Daniel Greenberg

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours